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Supp Table 1: NSW Refugee Health Service (RHS) screening protocol for refugee arrivals to Sydney,  
  2013-2014 
Age 
(years)years 
old) 
Routine tests performed Risk based tests performed** 
< 2 No routine blood tests  If indicated from family results or country of 
birth 
≥ 2 and <5 Full blood count 
Vitamin D 
Hepatitis B serology 
Strongyloides serology 
QuantiFERON-TB Gold**  
Ferritin  
Malarial parasites  
Schistosomiasis serology 
 
≥ 5 and <15  Full blood count 
Vitamin D  
Hepatitis B serology 
Strongyloides serology 
Ferritin  
Malarial parasites  
Schistosomiasis serology 
QuantiFERON-TB Gold 
≥ 15  Full blood count 
Vitamin D  
Hepatitis B serology 
Strongyloides serology 
Syphilis serology 
Ferritin 
Malarial parasites  
Schistosomiasis serology 
QuantiFERON-TB Gold 
Rubella serology 
Hepatitis C serology 
HIV serology 
*Other tests performed as indicated on clinical or public health grounds 
** Latent tuberculosis (TB) infection was tested for in two to five year olds as they are at greatest risk of 
developing severe TB disease. Although the QuantiFERON-TB Gold test is less validated compared to 
Mantoux testing in young children, this was a compromise as they were already having venepuncture.   
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Supp Table 2: RHS criteria for risk based testing 
Test Criteria 
Ferritin level Anaemia, history of iron deficiency 
Malarial 
parasites* 
Those who have lived or passed through any of the following in the last three 
months: 
 Sub-Saharan Africa 
 Indian subcontinent including India and Bangladesh (but excluding 
Nepal) 
 South-East Asia including Thailand and Indonesia (but excluding 
Malaysia)  
Schistosomiasis 
serology 
Recently arrived from Africa or Southeast Asia 
QuantiFERON- 
TB Gold 
Those at risk of/from latent TB infection 
Rubella serology Pre-menopausal females 
Hepatitis C 
serology 
Those from high risk countries including sub-Saharan Africa, Eastern Europe, 
Egypt, Vietnam, Pakistan and Burma/Myanmar or anyone with increased risk of 
blood borne viruses 
HIV serology Those greater than 15 years old from sub-Saharan Africa and Thai-Burma 
border, all pregnant women, those with other blood borne viruses identified or 
known/suspected risk factors 
*Malaria screening involved both thick and thin blood films and an antigen-based rapid detection test. 
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Supp Table 3: Number (%) of total patients tested, by age group (n = 3307) 
Age (years old) Number of patients % 
< 2  39 1.2 
≥ 2 and < 5  167 5.0 
≥5 and <15  678 20.5 
≥15 and < 35  1238 37.4 
≥35 and <60  955 28.9 
≥60  230 7.0 
 
 
 
 
 
Supp Table 4: Number (%) of total patients tested by gender (n = 3307) 
Gender Number of patients % 
Male 1690 51.1 
Female 1617 48.9 
 
 
  
Ngo CC, Maidment C, Atkins L, Eagar S, Smith MM. Blood screen findings in a 2-year cohort of newly arrived 
refugees to Sydney, Australia. Public Health Res Pract. 2018;28(1):e2811804 
 
Supp Table 5: Vitamin D deficiency by COB 
COB Vitamin D <50nmol/L  
n/nt % 
Afghanistan + Pakistan 161/235 68.5 
Myanmar 53/104 51.0 
Iran 109/142 76.8 
Iraq 1700/2059 82.6 
Syria 232/318 73.0 
Tibet + India 124/179 69.3 
   
Middle East (grouped) 1998/2538 78.7  (p < 0.0001)# 
n = number deficient in vitamin D 
nt = number tested for vitamin D levels 
# higher than non ME countries 
 
 
 
Supp Table 6: Vitamin D deficiency by gender in the Middle Eastern sub-group  
Vitamin D 
level 
All Male Female 
n/nt % n/nt % n/nt % 
<50nmol/L 2053/2538 80.9 936/1268 73.8# 1117/1270 88.0# 
30-49nmol/L 1124/2538 44.3 648/1268 51.1 476/1270 37.5 
12.5-29nmol/L 874/2538 34.4 282/1268 22.2 592/1270 46.6 
<12.5nmol/L 55/2538 2.2 6/1268 0.5 491/1270 3.9 
n = number deficient in vitamin D 
nt = number tested for vitamin D levels 
#  p < 0.0001 
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Supp Table 7: Vitamin D deficiency in under 5 year olds by COB 
COB Vitamin D <50nmol/L  
n/nt % 
All countries 114/201 56.7 
Afghanistan + Pakistan 9/12 75 
Myanmar 2/8 25 
Iran 3/4 75 
Iraq 78/139 56.1 
Syria 13/21 62 
Tibet + India 4/7 57 
   
Middle East (grouped) 94/164 57.3 
n = number deficient in vitamin D 
nt = number tested for vitamin D levels 
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Supp Table 8: Isolated positive anti-HBc by COB 
COB Isolated positive anti-HBc 
n/nt % 
All countries 44/3226 1.4 
Afghanistan + Pakistan 5/228 2.2 
Myanmar 7/104 6.7 
Iran 0/139 0 
Iraq 17/2027 0.8 
Syria 3/318 0.9 
Tibet + India 4/178 2.2 
   
Middle East (grouped) 20/2503 0.8 
n = number with a combination of detectable anti-HBc, undetectable HBsAg, anti-HBs <10IU/L  
nt = number tested 
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Supp Table 9: Anti-HBs <10 IU/L by COB and age 
COB All ages  <10 yrs old 10-19 yrs old >19 yrs old 
n/nt % n/nt % n/nt % n/nt % 
All countries 2127/3169 67.1 151/532 28.4 381/608 62.7 1595/2029 78.6 
Afghanistan + 
Pakistan 
148/224 66.1 20/45 44 27/42 64 101/137 73.7 
Myanmar 43/92 47 7/17 41 10/14 71 26/61 43 
Iran 87/137 63.5 5/13 39 9/19 47 73/105 69.5 
Iraq 1476/2016 73.2 84/343 24.5 255/377 67.6 1137/1296 87.7 
Syria 170/317 53.6 13/69 19 33/83 40 124/165 75.2 
Tibet + India 38/155 24.5 10/19 53 12/29 41 16/107 15.0 
         
Middle East 
(grouped) 
1744/2489 70.1 102/425 24.0 297/482 61.6 1345/1582 85.0 
n = number of patients with anti-HBs <10IU/L. Only those with negative HBsAg were included in the 
calculation. Occasionally, the anti-HBs test was not done by the laboratory despite being requested. 
nt = number tested for Hepatitis B serology. Only those with negative HBsAg were included in the 
calculation. 
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Supp Table 10: Prevalence of positive and equivocal strongyloides serology by COB 
COB Positive result Equivocal result 
n/nt % n/nt % 
All countries 133/3241 4.1 72/3241 2.2 
Afghanistan + Pakistan 4/232 1.7 5/232 2.2 
Myanmar 15/103 14.6 0/103 0 
Iran 5/139 3.6 3/139 2.2 
Iraq 78/2042 3.8 50/2042 2.4 
Syria 8/317 2.5 2/317 0.6 
Tibet + India 11/181 6.1 6/181 3.3 
     
Middle East (grouped) 91/2517 3.6# 55/2517 2.2 
n = number of patients with Assay S/Co ratio range 0.90-1.10 (equivocal) and >1.10 (positive) 
nt = number tested for strongyloides serology 
# lower than non ME countries, p=0.02  
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Supp Table 11: Rates of syphilis reactivity by COB 
COB Reactive to treponemal antibody 
n/nt % 
All countries 27/2565 1.1 
Afghanistan + Pakistan 0/178 0 
Myanmar 2/82 2 
Iran 0/125 0 
Iraq 18/1646 1.1 
Syria 0/200 0 
Tibet + India 5/140 3.6 
   
Middle East (grouped) 18/1990 0.9 
n = number reactive to treponemal antibody  
nt = number tested for syphilis serology  
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Supp Table 12: Rubella non-immunity rates by COB and gender 
COB Both genders Male 
 
Female 
 
n/nt % n/nt % n/nt % 
All countries 90/949 9.5 22/211 10.4 68/738 9.2 
Afghanistan + 
Pakistan 
4/61 7 0/9 0 4/52 8 
Myanmar 4/30 13 0/5 0 4/25 16 
Iran 8/37 22 3/10 30 5/27 19 
Iraq 53/562 9.4 14/117 12.0 39/445 8.8 
Syria 8/135 5.9 2/41 5 6/94 6 
Tibet + India 9/57 16 3/11 27 6/46 13 
       
Middle East 
(grouped) 
70/742 9.4 (NS) 19/171 11.1 51/571 8.9 
n = number of patients with Rubella IgG <10 IU/ml 
nt = number tested for Rubella serology 
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Table 13: Positive/indeterminate hepatitis C antibody rates by COB 
COB Positive or indeterminate for anti-HCV 
n/nt % 
All countries 10/842 1.2 
Afghanistan + Pakistan 2/60 3 
Myanmar 5*/51 10 
Iran 0/44 0 
Iraq 2/501 0.4 
Syria 0/45 0 
Tibet + India 0/38 0 
   
Middle East (grouped) 2/594 0.3 
n = number positive or indeterminate for anti-HCV 
nt = number tested for anti-HCV 
* 3 patients were positive and 2 patients were indeterminate 
 
 
Table 17: HIV test results 
COB HIV positive  
n/nt % 
All countries 0/236* 0 
Middle East 
(grouped) 
0/163** 0 
n = number positive for HIV 1/2 antigen antibody 
nt = number tested for HIV 1/2 antigen and antibody 
* 10 of the 236 were under 15 years old  
** 2 of the 181 were under 15 years old 
(those greater than 15 years old would also have tested negative at their visa medical assessment). 
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Table 14: Rates of latent tuberculosis infection by age 
IGRA test result < 2 yrs old 2-5 yrs old > 5 yrs old 
n/nt % n/nt % n/nt % 
Positive 4/33 12 3/135 2.2 7/87 8 
Indeterminate 0/33 0 1/135 0.8 1/87 1 
n = number positive/indeterminate for Tuberculosis 
nt = number tested for Tuberculosis 
 
